NCT00951522View on ClinicalTrials.gov

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Cystic FibrosisMucociliary ClearanceAirway Hydration

Interventions

DRUG

GS-9411

Inhaled GS-9411 dissolved in sterile saline

DRUG

Placebo

Inhaled placebo in sterile saline

Trial Locations (1)

3004

Nucleus Network, Ltd., Melbourne

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY